I think by really overlaying all these different data sets, we can move from coincidental findings to consistent findings, and then this protein NOTUM really is the strong, consistent hit that we keep seeing coming back. Now, what we don’t know yet is whether this is a direct causal agent, right, whether NOTUM directly acts on T-cells. And to be honest, when we do experiments putting T-cells and cancer cells in addition to NOTUM, we don’t see much of an effect there...
I think by really overlaying all these different data sets, we can move from coincidental findings to consistent findings, and then this protein NOTUM really is the strong, consistent hit that we keep seeing coming back. Now, what we don’t know yet is whether this is a direct causal agent, right, whether NOTUM directly acts on T-cells. And to be honest, when we do experiments putting T-cells and cancer cells in addition to NOTUM, we don’t see much of an effect there. So it might work indirectly through additional cells like fibroblasts or other immune cells. So we don’t know yet whether this is a marker of immune-excluded cancers or a direct causal agent. But what it tells us is that the secretome is fundamentally altered in those tumors that escape from immune attack versus those that do.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.